NexgenRx Inc.
TSX VENTURE : NXG

NexgenRx Inc.

November 20, 2014 13:45 ET

NexgenRx Announces Third Quarter of 2014 Results

TORONTO, ONTARIO--(Marketwired - Nov. 20, 2014) - NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to announce its Q3 2014 results.

For the third quarter ended September 30, 2014 transaction and administration revenue was $1,015,336, generating gross profit of $794,106 and a net loss of $172,510.

"During the quarter, we focused on expanding our sales efforts, creating market awareness and building relationships with several national consulting firms and regional market sources in Western Canada and the Atlantic Region. We have expanded our National presence with the opening of our sales office in Vancouver and hiring our Western Regional VP, Sales in September." stated Ron Loucks, President and CEO. "We are pleased to announce the completion of the design and development of NexMobile, our mobile app technology compatible with all iPhone, Android and other smart devices. Plan members have the ability to check plan design, drug formulary choices, banking information and real time claims submission and adjudication, all from the convenience of their hand -held smart devices," he added.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at www.nexgenrx.com.

Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release."

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    416.695.3393 x801

    NexgenRx Inc.
    Taba Merrikh
    Director of Finance
    416-695-3393x803
    www.nexgenrx.com